Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

ema.europa.eu

What's new

Get the latest updates from What's new directly as they happen.

Follow now 252 followers

Latest posts

Last updated 2 days ago

Human medicines European public assessment report (EPAR): Gilenya, fingolimod, Date of authorisation: 17/03/2011, Revision: 38, Status: Authorised

2 days ago

Human medicines European public assessment report (EPAR): Gilenya, fingolimod, Date of authorisation...

Cyanokit

2 days ago

Cyanokit

Veterinary medicines European public assessment report (EPAR): Nobivac L4, Vaccine to prevent Leptospira infections in dogs, Status: Authorised

2 days ago

Veterinary medicines European public assessment report (EPAR): Nobivac L4, Vaccine to prevent...

Trametinib product-specific bioequivalence guideline

2 days ago

Trametinib product-specific bioequivalence guideline

Human medicines European public assessment report (EPAR): Idelvion, albutrepenonacog alfa, Date of authorisation: 11/05/2016, Revision: 13, Status: Authorised

2 days ago

Human medicines European public assessment report (EPAR): Idelvion, albutrepenonacog alfa, Date of...

Human medicines European public assessment report (EPAR): Axitinib Accord, axitinib, Date of authorisation: 19/09/2024, Revision: 1, Status: Authorised

2 days ago

Human medicines European public assessment report (EPAR): Axitinib Accord, axitinib, Date of...

Human medicines European public assessment report (EPAR): Carbaglu, carglumic acid, Date of authorisation: 24/01/2003, Revision: 20, Status: Authorised

2 days ago

Human medicines European public assessment report (EPAR): Carbaglu, carglumic acid, Date of...

Human medicines European public assessment report (EPAR): Vocabria, cabotegravir, Date of authorisation: 17/12/2020, Revision: 11, Status: Authorised

2 days ago

Human medicines European public assessment report (EPAR): Vocabria, cabotegravir, Date of authorisation...

Human medicines European public assessment report (EPAR): Tevimbra, tislelizumab, Date of authorisation: 15/09/2023, Revision: 7, Status: Authorised

2 days ago

Human medicines European public assessment report (EPAR): Tevimbra, tislelizumab, Date of authorisation...